MedPath

Comparison of different doses of dexmedetomidine with Ropivacaine for caesarean section under spinal anaesthesia

Phase 3
Conditions
Health Condition 1: O82- Encounter for cesarean delivery without indicationHealth Condition 2: O30-O48- Maternal care related to the fetus and amniotic cavity and possible delivery problems
Registration Number
CTRI/2023/10/059021
Lead Sponsor
Dr YSR Government Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA Physical status 1and 2

fullterm parturients

scheduled for elective lower segment caesarean section surgery under spinal anaesthesia

Exclusion Criteria

Gestational age less than 36weeks

patients body mass index >35kg/m2

active or earlylabour

history of more than one previous caesarean delivery

placenta previa

ruptured membranes

intrauterine growth restriction

hypertension or preeclampsia

diabetes or gestationaldiabetes

any contraindications to regionalanaesthesia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prolongation of duration of analgesiaTimepoint: Duration of analgesia assessed after 6,12,24,36 hours
Secondary Outcome Measures
NameTimeMethod
Onset & duration of sensorimotor blockade, hemodynamic variables, sedation score, & adverse effectsTimepoint: Two point regression & bromage scale checked after surgery, 2,4,6,8,10,16,24 hours after surgery
© Copyright 2025. All Rights Reserved by MedPath